医渡科技(02158)发布公告，于2026年2月2日斥资499.84万港元回购88.54万股。 ...

智通财经APP讯，医渡科技(02158)发布公告，于2026年2月2日斥资499.84万港元回购88.54万股。 ...

格隆汇2月2日丨医渡科技(02158.HK)公告，2月2日耗资499.8万港元回购88.5万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 醫渡科技有限公司 呈交日期： 2026年2月2日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | | 事件 | 已發行股份（不包括庫存股 ...

Core Viewpoint - The company, Yidu Tech (02158), is actively repurchasing shares, signaling confidence in its long-term value while also making significant strides in business collaborations within the healthcare sector [1] Group 1: Share Repurchase - On January 30, Yidu Tech repurchased approximately 786,000 shares at around HKD 5.8 per share, costing over HKD 4.5 million [1] - The total amount spent on share repurchases over the past five days exceeds HKD 9.5 million, indicating a strong commitment to enhancing shareholder value [1] Group 2: Business Collaborations - Yidu Tech has established a strategic partnership with the Nanshan District People's Hospital in Shenzhen, launching the first domestic "AI + Health Management" innovative system that covers "full-time, full-domain, full-population, and full-cycle" [1] - This initiative aims to create a closed-loop AI medical ecosystem from research and development to application and transformation, marking a significant step in the implementation of smart healthcare solutions [1] Group 3: Market Developments - The company has reported that the number of participants in the 2026 "Beijing Universal Health Insurance" program has surpassed 4.5 million, showcasing its operational capabilities [1] - Additionally, Yidu Tech has collaborated with the First Affiliated Hospital of Chongqing Medical University to launch an "AI Assistant for General Medicine," further expanding its influence in the healthcare sector [1] - Market observers note that the combination of continuous share repurchases and multiple business collaborations highlights the company's dual strategy of "technological breakthroughs + scenario implementation," deepening its impact in the fields of medical intelligence and universal health [1]

Core Viewpoint - The company, Yidu Tech (02158), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Buyback Details - The company will repurchase 786,300 shares at a total cost of HKD 4.5579 million [1] - The buyback price per share ranges from HKD 5.72 to HKD 6.00 [1]

Group 1 - The company, Yidu Tech (02158), announced a share buyback plan on January 30, 2026, involving an expenditure of HKD 4.5579 million to repurchase 786,300 shares [1] - The buyback price is set between HKD 5.72 and HKD 6.00 per share [1]

格隆汇1月30日丨医渡科技(02158.HK)公告，1月30日耗资455.8万港元回购78.6万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 醫渡科技有限公司 呈交日期： 2026年1月30日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件 ...

Core Insights - Shenzhen Nanshan District People's Hospital and Yidu Technology have established a strategic partnership to launch an "AI + Health Management" innovative system, aiming to create a closed-loop AI medical ecosystem covering "full-time, full-domain, full-population, and full-cycle" [1][3] Group 1: Strategic Collaboration - The collaboration aims to leverage Yidu Technology's AI capabilities to build a comprehensive health service system that enhances the medical service model and improves public health outcomes [3][4] - The partnership will focus on constructing an "AI Parallel Hospital" and a "24-hour Digital Research Institute," exploring compliant development of medical data elements [4] Group 2: Digital Transformation in Healthcare - The innovative system will integrate clinical diagnosis and health management, providing intelligent services throughout the entire patient journey, from prevention to rehabilitation [3][5] - Yidu Technology's CEO emphasized the company's commitment to empowering the digital transformation of Shenzhen's healthcare industry through systematic capabilities in medical data governance and AI platform construction [5][6] Group 3: Implementation and Future Prospects - The collaboration is expected to enhance hospital operational efficiency, optimize patient service experiences, and strengthen health management capabilities [6][7] - Shenzhen aims to contribute to the intelligent upgrade of the healthcare industry in the Greater Bay Area by exploring replicable paths and providing a "Shenzhen practice" model for digital transformation [7]